GlassScriptPhysician profile
Michael D Kelly
NPI 1023124385
$25,384.80
in general payments reported to CMS, 2019-2025
20 companies · $14K in 2025
The $14K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.59 · 2020: $72.09 · 2021: $261 · 2022: $174 · 2023: $25.99 · 2024: $10K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Food and Beverage: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,600.00 |
| Food and Beverage | $245.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $24,600.00 | 2024-2025 | Bovine Collagen |
| Exeltis, USA INC. | $114.47 | 2019-2025 | Slynd |
| Abbvie INC. | $111.67 | 2021-2022 | |
| Hologic Sales and Service, LLC | $86.60 | 2020-2025 | Aptima |
| Ethicon US, LLC | $67.13 | 2025 | Stratafix, Vistaseal, Evarrest |
| Evofem Biosciences, INC. | $50.02 | 2021-2022 | |
| Optumhealth Care Solutions, LLC | $49.59 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Mission Pharmacal Company | $47.33 | 2019-2021 | |
| Organon LLC | $42.00 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $32.15 | 2021 | |
| Boston Scientific Corporation | $28.65 | 2021-2023 | Spaceoar Vue System - 10ml |
| Dexcom, INC. | $23.39 | 2024 | Dexcom G6 Transmitter |
| Coopersurgical, INC. | $20.36 | 2022 | |
| Mylan Pharmaceuticals INC. | $19.90 | 2020 | |
| Millicent US INC | $18.04 | 2025 | Femlyv |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $16.50 | 2021 | |
| Avion Pharmaceuticals | $14.60 | 2021 | |
| Aspira Women'S Health INC | $14.55 | 2024 | Ova1 |
| Shield Therapeutics INC | $14.55 | 2022 | |
| Therapeuticsmd, INC. | $13.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.